Evidence map›Paper›PMID 33824876›Full record

Trial reportBioMed research international2021

Jingjing Chen, Yuanfang Xu, Hongyuan Hu, Tianbo Jin

Open access · hybridAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jingjing ChenGynecology Department, People's Hospital of Wanning, Wanning, 571500 Hainan, China.ORCID https://orcid.org/0000-0001-9702-4559
Yuanfang XuGynecology Department, People's Hospital of Wanning, Wanning, 571500 Hainan, China.ORCID https://orcid.org/0000-0001-7962-5617
Hongyuan HuObstetrical Department, People's Hospital of Wanning, Wanning, 571500 Hainan, China.ORCID https://orcid.org/0000-0002-0641-2976
Tianbo JinKey Laboratory of Molecular Mechanism and Intervention Research for Plateau Diseases of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, 712082 Shaanxi, China.ORCID https://orcid.org/0000-0001-8327-6501
First People's Hospital of Nanning · CNMinistry of Education of the People's Republic of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer (CC) is the second most common tumor in women worldwide. Studies have been accepted that genetic variations play an important role in the development of CC. The aim of this study was to evaluate the impact of

methods508 patients of cervical cancer and 497 healthy subjects were recruited to determine the impact of

resultsOur study showed that rs11904127 (OR 0.79,

conclusionRs11904127 and rs62162674 in

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultAsian PeopleChinaFemaleHumansMiddle AgedNeoplasm ProteinsTranscription Factor 7-Like 1 ProteinUterine Cervical NeoplasmsNeoplasm ProteinsTCF7L1 protein, humanTranscription Factor 7-Like 1 Protein

Identifiers

PMID33824876
PMCPMC8007361
OpenAlexW3138876331

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.